Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palliative Radiotherapy in Addition to Self-expanding Metal Stent for Improving Dysphagia and Survival in Advanced Oesophageal Cancer: ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study.

NCT01915693 is registered in ClinicalTrials.gov with Lisette Nixon as lead sponsor.

NCT NCT01915693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01915693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palliative Radiotherapy in Addition to Self-expanding Metal Stent for Improving Dysphagia and Survival in Advanced Oesophageal Cancer: ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study.
Lead sponsor
Lisette Nixon
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
November 30, 2018
Enrollment
220 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

oesophageal cancer